Patent · US Active

Osteoprotegerin in neuroprotection

US8716229B2 · kind B2 · utility

1Cited by
1References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 8, 2012
Grant dateMay 6, 2014
Priority date—
Expiry dateNov 8, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for treating neurodegeneration, e.g., sensorineural hearing loss, or a demyelinating disease, using bisphosphonates, ERK kinase inhibitors, and osteoprotegerin (OPG) proteins or nucleic acids.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.